These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer's disease. Zhang Y; Wang Y; Shi C; Shen M; Lu F Transl Neurodegener; 2021 Feb; 10(1):6. PubMed ID: 33517891 [TBL] [Abstract][Full Text] [Related]
4. [Retinal Imaging as Potential Biomarkers for Dementia]. Sasaki M Brain Nerve; 2021 Nov; 73(11):1209-1216. PubMed ID: 34759057 [TBL] [Abstract][Full Text] [Related]
5. Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease. Ferrari L; Huang SC; Magnani G; Ambrosi A; Comi G; Leocani L J Alzheimers Dis; 2017; 56(3):1101-1107. PubMed ID: 28106555 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal retinal layer changes in preclinical Alzheimer's disease. van de Kreeke JA; Nguyen HT; Konijnenberg E; Tomassen J; den Braber A; Ten Kate M; Yaqub M; van Berckel B; Lammertsma AA; Boomsma DI; Tan HS; Visser PJ; Verbraak FD Acta Ophthalmol; 2021 Aug; 99(5):538-544. PubMed ID: 33073531 [TBL] [Abstract][Full Text] [Related]
7. Choroidal thinning as a new finding in Alzheimer's disease: evidence from enhanced depth imaging spectral domain optical coherence tomography. Gharbiya M; Trebbastoni A; Parisi F; Manganiello S; Cruciani F; D'Antonio F; De Vico U; Imbriano L; Campanelli A; De Lena C J Alzheimers Dis; 2014; 40(4):907-17. PubMed ID: 24577467 [TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease pathophysiology in the Retina. Gaire BP; Koronyo Y; Fuchs DT; Shi H; Rentsendorj A; Danziger R; Vit JP; Mirzaei N; Doustar J; Sheyn J; Hampel H; Vergallo A; Davis MR; Jallow O; Baldacci F; Verdooner SR; Barron E; Mirzaei M; Gupta VK; Graham SL; Tayebi M; Carare RO; Sadun AA; Miller CA; Dumitrascu OM; Lahiri S; Gao L; Black KL; Koronyo-Hamaoui M Prog Retin Eye Res; 2024 Jul; 101():101273. PubMed ID: 38759947 [TBL] [Abstract][Full Text] [Related]
9. Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer's disease patients. Lemmens S; Van Craenendonck T; Van Eijgen J; De Groef L; Bruffaerts R; de Jesus DA; Charle W; Jayapala M; Sunaric-Mégevand G; Standaert A; Theunis J; Van Keer K; Vandenbulcke M; Moons L; Vandenberghe R; De Boever P; Stalmans I Alzheimers Res Ther; 2020 Nov; 12(1):144. PubMed ID: 33172499 [TBL] [Abstract][Full Text] [Related]
10. Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography-angiography. Biscetti L; Lupidi M; Luchetti E; Eusebi P; Gujar R; Vergaro A; Cagini C; Parnetti L Eur J Neurol; 2021 Jul; 28(7):2185-2191. PubMed ID: 33852770 [TBL] [Abstract][Full Text] [Related]
11. Visualization of Focal Thinning of the Ganglion Cell-Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer's Disease. Shao Y; Jiang H; Wei Y; Shi Y; Shi C; Wright CB; Sun X; Vanner EA; Rodriguez AD; Lam BL; Rundek T; Baumel BS; Gameiro GR; Dong C; Wang J J Alzheimers Dis; 2018; 64(4):1261-1273. PubMed ID: 30040712 [TBL] [Abstract][Full Text] [Related]
12. Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances. Gupta VB; Chitranshi N; den Haan J; Mirzaei M; You Y; Lim JK; Basavarajappa D; Godinez A; Di Angelantonio S; Sachdev P; Salekdeh GH; Bouwman F; Graham S; Gupta V Prog Retin Eye Res; 2021 May; 82():100899. PubMed ID: 32890742 [TBL] [Abstract][Full Text] [Related]
13. In Vivo Assessment of Retinal Biomarkers by Hyperspectral Imaging: Early Detection of Alzheimer's Disease. More SS; Beach JM; McClelland C; Mokhtarzadeh A; Vince R ACS Chem Neurosci; 2019 Nov; 10(11):4492-4501. PubMed ID: 31603648 [TBL] [Abstract][Full Text] [Related]
14. A systematic survey of advances in retinal imaging modalities for Alzheimer's disease diagnosis. Vij R; Arora S Metab Brain Dis; 2022 Oct; 37(7):2213-2243. PubMed ID: 35290546 [TBL] [Abstract][Full Text] [Related]
15. Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis. Czakó C; Kovács T; Ungvari Z; Csiszar A; Yabluchanskiy A; Conley S; Csipo T; Lipecz A; Horváth H; Sándor GL; István L; Logan T; Nagy ZZ; Kovács I Geroscience; 2020 Dec; 42(6):1499-1525. PubMed ID: 33011937 [TBL] [Abstract][Full Text] [Related]
16. [How far reaches earliness of optical coherence tomography in cognitive impairment]. Gimenez-Castejon D; Gomez-Gallego M; Martinez-Martinez ML; Dudekova M; Lajara-Blesa J Rev Neurol; 2016 Jul; 63(1):5-10. PubMed ID: 27345274 [TBL] [Abstract][Full Text] [Related]
17. Correlation between retinal nerve fibre layer thickness and white matter lesions in Alzheimer's disease. Carazo-Barrios L; Archidona-Arranz A; Claros-Ruiz A; García-Basterra I; Garzón-Maldonado FJ; Serrano-Castro V; Gutiérrez-Bedmar M; Barbancho MÁ; De la Cruz Cosme C; García-Campos JM; García-Casares N Int J Geriatr Psychiatry; 2021 Jun; 36(6):935-942. PubMed ID: 33387372 [TBL] [Abstract][Full Text] [Related]
18. [The relationship between cognitive impairment and changes in retinal neuroarchitectonics]. Bogolepova AN; Makhnovich EV; Jyravleva AN Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(9):7-13. PubMed ID: 33081441 [TBL] [Abstract][Full Text] [Related]
19. [Perspectives of the diagnosis of Alzheimer's disease using optic coherent tomography]. Bogolepova AN; Zhuravleva AN; Makhnovich EV Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):112-117. PubMed ID: 29053131 [TBL] [Abstract][Full Text] [Related]
20. Macular Thickness Measurements with Frequency Domain-OCT for Quantification of Retinal Neural Loss and its Correlation with Cognitive Impairment in Alzheimer's Disease. Cunha LP; Lopes LC; Costa-Cunha LV; Costa CF; Pires LA; Almeida AL; Monteiro ML PLoS One; 2016; 11(4):e0153830. PubMed ID: 27104962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]